>欧洲即时诊断检测 (POCT) 市场，产品（仪器、消耗品和试剂等）、应用（血糖、心脏监测、凝血、全血分析、生命体征监测、传染病检测、尿液分析、胆固醇检测等）、最终用户（实验室、医院、诊所、门诊中心、家庭护理、辅助生活设施、药房/药店等）、检测模式（基于处方的检测和 OTC 检测）、分销渠道（直销、第三方分销商和在线销售）—— 行业趋势和预测到 2029 年。
欧洲即时诊断检测 (POCT) 市场分析与洞察
即时检测 (POCT) 的特点是可以在患者附近进行检测，可以立即做出医疗决策，包括结果和监测。传染病和慢性病患病率的增加、诊断率的提高以及对家庭护理检测的偏好增加是推动市场增长的一些主要驱动因素。
然而，与实验室获得的测试结果不一致、成本高以及缺乏训练有素的人员是阻碍市场增长的一些挑战。
欧洲即时诊断检测 (POCT) 市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场的复合年增长率为 8.8%，预计到 2029 年将达到 130.8533 亿美元。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史性的一年 |
2020 (可定制至 2019-2014) |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按产品（仪器、耗材及试剂等）、应用（血糖、心脏监测、凝血、全血分析、生命体征监测、传染病检测、尿液分析、胆固醇检测等）、最终用户（实验室、医院、诊所、流动中心、家庭护理、辅助生活设施、药房/药店等）、检测方式（处方检测和非处方检测）、分销渠道（直销、第三方分销商和线上销售） |
|
覆盖国家 |
德国、法国、英国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区 |
|
涵盖的市场参与者 |
Siemens Healthcare GmbH、F. Hoffmann-La Roche Ltd.、Quidel Corporation Trividia Health, Inc.、Nova Biomedical、PTS Diagnostics、Trinity Biotech、LumiraDx、Sekisui Diagnostics、Chembio Diagnostics, Inc.、BD、Thermo Fisher Scientific Inc.、Abbott、Danaher、binx health, inc、QuantuMDx Group Ltd.、Werfen、Thermo Fisher Scientific、Abaxis、EKF Diagnostics 和 Sysmex Europe SE |
市场定义
即时检测 (POCT) 也称为患者随访检测，它允许医生在几分钟内（而不是几个小时）准确测量实时、实验室质量的诊断结果。目前，有各种产品可以提供快速准确的结果并帮助患者获得更好的结果，预计这将为市场增长提供各种其他机会。然而，实验室结果不一致和 POCT 产品成本高昂预计将在预测期内抑制市场增长。
欧洲即时诊断检测 (POCT) 市场报告提供了市场份额、新发展、产品线分析以及国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
欧洲即时诊断检测 (POCT) 市场动态
驱动程序
- 传染病和慢性病发病率不断上升
癌症、糖尿病和心血管疾病等传染病和慢性病的发病率在整个欧洲迅速上升。根据世界卫生组织 (WHO) 的数据，慢性病约占死亡人数的 60%。在欧洲，慢性病数量增加的主要原因是老年人口数量的增加。这些疾病的增长率与 POCT 设备的市场增长成正比，因为它们用于诊断几乎所有疾病。我们还知道，由于健康状况的下降始于衰老，因此慢性病的发病率及其相关因素也会随着时间的推移而增加。然而，随着发病率的上升，医疗保健系统和健康状况也在改善，这是由于人们对 POCT 设备的认识和采用，这些设备有助于诊断多种慢性病，从而推动了市场增长。
例如，
- 2017年10月，根据施普林格出版公司的一份报告，欧盟85%的死亡是由癌症、心血管疾病、慢性呼吸系统疾病、糖尿病和精神疾病等慢性疾病引起的
欧洲癌症、哮喘、心脏病等慢性病发病率不断上升，提高了人们对疾病早期诊断的使用和认识。这种认识使人们购买了更多的医疗保险，包括定期进行几乎涵盖所有检查的全身检查。与此同时，慢性病患者人数正在迅速增加。
因此，慢性病患病率的大幅上升将成为市场增长的主要动力，因为 POCT 设备可以有效地管理疾病，并在需要时提供更好的舒适度和监测治疗。
- 提高就诊率
医疗保健专业人员的提高和对进行测试的专业人员的定期培训有助于提高该地区的诊断率，包括成功诊断癌症、心血管疾病、2 型糖尿病等慢性疾病的人数增加。随着疾病负担的增加，诊断率也会提高。医疗保健和 IT 专业人员有能力降低错误的可能性，并正在尝试提高寻求 POCT 的比率。除此之外，他们还帮助确定和检测与之相关的风险。也许，为了提高诊断率，IT 专业人员也会评估用户体验。
为了支持 POCT 流程，引入了一种方法，包括管理覆盖范围、专业人员用于诊断和评估活动的时间，这将有助于提高信息的准确率并有助于做出更好的诊断决策。因此，医疗保健和 IT 专业人员的努力、医疗保健专业人员培训的改进、患者护理体系的改变以及该地区诊断寻求率的提高正在推动市场增长。
- 家庭护理检测的受欢迎程度日益提升
家庭护理检测需求的增加减少了错误，提高了安全性，确保了临床信息的质量，这些信息将在适当的时间和地点提供，也有助于了解老年人的医疗紧急情况。由于老年人口的增加，市场一直在增长，从而增加了对家庭护理检测的需求。借助尖端的现代技术，家庭医疗保健成本大幅降低，人们得到了有效的帮助。因此，对家庭医疗保健服务的偏好增加将推动对 POCT 设备的需求，从而推动市场增长。
机会
- 市场参与者的战略举措
欧洲慢性病和传染病的发病率不断上升，老年人口不断增加，需要新的先进 POCT 试剂盒和解决方案，以提高有效率并缩短周期时间，同时也需要改善医疗管理和诊断以提高质量。主要市场领导者致力于充分满足医疗保健专业人士的需求，并投入时间进行研究以生产更好的产品、试剂盒和试剂。
这些公司的战略举措包括收购和重点细分产品发布，有助于他们扩大和增强公司的产品组合，最终将带来更多收入。因此，市场参与者的这些战略举措是一个帮助他们推动市场增长的机会。
克制/挑战
- 与实验室的测试结果不一致
与实验室检测标准相比，POCT 结果可能存在差异，且由未接受过临床实验室科学培训的临床人员执行。POCT 无法完成标准化和其他基本标准，这对市场增长构成了重大挑战。
鉴于 POCT 研究的优势，一些缺点不一定被视为最安全的选择。由于实验室分析仪的灵敏度和精确度，临床实验室人员非常了解分析方法，并且更可靠。相比之下，由医疗保健人员而不是实验室合格人员进行的测试会导致错误，原因是缺乏对质量管理和质量保证程序重要性的认识。因此，由于缺乏知识，POCT 面临着满足所有特定测试标准的挑战，因此可以期待实验室测试获得更精确和准确的结果。
最新动态
- 2022 年 5 月，雅培更新了 i-STAT 软件，供医院和门诊机构实时提供解决方案。该软件具有高效率、成本效益高、提供高质量的患者护理决策
- 2022 年 5 月，EKF Diagnostics 宣布推出其新的 EKF Link 数字连接解决方案，用于在一个集中平台上安全管理 POC 分析仪及其相关数据
欧洲即时诊断检测 (POCT) 市场范围
欧洲即时诊断检测 (POCT) 市场细分为产品、应用、最终用户、检测模式和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
产品
- 仪器
- 耗材和试剂
- 其他的
根据产品，市场分为仪器、消耗品和试剂以及其他。
应用
- 血糖
- 心脏监测
- 凝血
- 全血分析
- 生命体征监测
- 传染病检测
- 尿液分析
- 胆固醇检测
- 其他的
根据应用，市场细分为血糖、心脏监测、凝血、全血分析、生命体征监测、传染病检测、尿液分析、胆固醇检测等。
最终用户
- 实验室
- 医院
- 诊所
- 流动中心
- 家庭护理
- 辅助生活设施
- 药房/药店
- 其他的
根据最终用户，市场分为实验室、医院、诊所、门诊中心、家庭护理、辅助生活设施、药房/药店和其他。
测试方式
- 基于处方的测试
- OTC测试
根据测试模式，市场分为处方测试和非处方测试。
分销渠道
- 直销
- 第三方分销商
- 网上销售
根据分销渠道，市场分为直销、第三方分销商和在线销售。
欧洲即时诊断检测 (POCT) 市场区域分析/见解
对欧洲即时诊断检测 (POCT) 市场进行了分析，并按产品、应用、最终用户、检测模式和分销渠道提供了市场规模洞察和趋势。
该市场涵盖的国家包括德国、法国、英国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他国家。德国在市场份额和市场收入方面占据欧洲即时诊断检测 (POCT) 市场的主导地位，并将在预测期内继续保持主导地位。这是由于欧洲地区对即时诊断检测 (POCT) 设备的认识度不断提高。
报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。
竞争格局和欧洲即时诊断检测 (POCT) 市场份额分析
即时诊断检测市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对即时诊断检测市场的关注有关。
该市场的一些主要参与者包括西门子医疗有限公司、罗氏公司、Quidel Corporation Trividia Health, Inc.、Nova Biomedical、PTS Diagnostics、Trinity Biotech、LumiraDx、Sekisui Diagnostics、Chembio Diagnostics, Inc.、BD、赛默飞世尔科技公司、雅培、丹纳赫、binx health, Inc.、QuantuMDx Group Ltd.、Werfen、赛默飞世尔科技、Abaxis、EKF Diagnostics 和 Sysmex Europe SE 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE POINT OF CARE TESTING (POCT) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF INFECTIOUS AND CHRONIC DISEASES
5.1.2 IMPROVED DIAGNOSIS-SEEKING RATE
5.1.3 DEMAND FOR WEARABLE OR PORTABLE GLUCOSE MONITORING DEVICES
5.1.4 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 LACK OF ACCURACY
5.2.2 HIGH COST OF PRODUCT
5.2.3 LACK OF TRAINING
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING AWARENESS AND GOVERNMENT FUNDING
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 IMPROPER CARE OF POCT DEVICES
6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 INSTRUMENTS
6.2.1 MOBILE PLATFORM (SMALL)
6.2.2 FACILITY-BASED PLATFORMS (LARGE POCT PLATFORM)
6.3 CONSUMABLES & REAGENTS
6.4 OTHERS
7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 BLOOD GLUCOSE
7.3 INFECTIOUS DISEASE TESTING
7.4 CARDIAC MONITORING
7.5 COAGULATION
7.6 WHOLE BLOOD ANALYSIS
7.7 CHOLESTEROL TESTING
7.8 VITAL SIGN MONITORING
7.9 URINE ANALYSIS
7.1 OTHERS
8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER
8.1 OVERVIEW
8.2 LABORATORIES
8.3 HOSPITALS
8.4 CLINICS
8.5 HOMECARE
8.6 AMBULATORY CENTERS
8.7 ASSISTED LIVING FACILITIES
8.8 PHARMACIES/DRUG STORES
8.9 OTHERS
9 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING
9.1 OVERVIEW
9.2 PRESCRIPTION BASED TESTING
9.3 OTC TESTING
10 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 THIRD PARTY DISTRIBUTOR
10.3 DIRECT SALES
10.4 ONLINE SALES
11 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY
11.1 GERMANY
11.2 U.K.
11.3 FRANCE
11.4 SPAIN
11.5 ITALY
11.6 RUSSIA
11.7 NETHERLANDS
11.8 SWITZERLAND
11.9 TURKEY
11.1 BELGIUM
11.11 REST OF EUROPE
12 EUROPE POINT OF CARE TESTING (POCT) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 F. HOFFMANN-LA ROCHE LTD
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 SIEMENS HEALTHCARE GMBH
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 WERFEN
14.3.1 COMPANY SNAPSHOT
14.3.2 PRODUCT PORTFOLIO
14.3.3 RECENT DEVELOPMENT
14.4 SYSMEX EUROPE SE.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 DANAHER
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 QUIDEL CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENTS
14.7 LUMIRAXDX
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BD
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 ABBOTT
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENTS
14.1 ABAXIS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 BINX HEALTH, INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 CHEMBIO DIAGNOSTICS SYSTEMS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENTS
14.13 EKF DIAGNOSTICS
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 NOVA BIOMEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 PTS DIAGNOSTICS
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 SEKISUI DIAGNOSTICS
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 TRINITY BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 TRIVIDIA HEALTH, INC.
14.18.1 PRODUCT PORTFOLIO
14.18.2 RECENT DEVELOPMENT
14.19 THERMO FISHER SCIENTIFIC INC. (2021)
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 QUANTUMDX GROUP LTD.
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
TABLE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 2 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 3 EUROPE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY VOLUME, 2020-2029 (MILLION UNITS)
TABLE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 9 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 10 GERMANY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 11 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 12 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 13 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 14 GERMANY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 15 U.K. POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 16 U.K. INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 17 U.K. POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 U.K. POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 19 U.K. POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 20 U.K. POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 21 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 22 FRANCE INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 23 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 25 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 26 FRANCE POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 27 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 28 SPAIN INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 29 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 31 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 32 SPAIN POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 33 ITALY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 34 ITALY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 35 ITALY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 ITALY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 37 ITALY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 38 ITALY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 39 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 40 RUSSIA INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 41 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 42 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 43 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 44 RUSSIA POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 45 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 46 NETHERLANDS INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 47 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 48 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 50 NETHERLANDS POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 52 SWITZERLAND INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 54 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 56 SWITZERLAND POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 58 TURKEY INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 59 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 60 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 62 TURKEY POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 63 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 64 BELGIUM INSTRUMENTS IN POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 66 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 67 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY MODE OF TESTING, 2020-2029 (USD MILLION)
TABLE 68 BELGIUM POINT OF CARE TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 69 REST OF EUROPE POINT OF CARE TESTING (POCT) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 EUROPE POINT OF CARE TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE POINT OF CARE TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE POINT OF CARE TESTING (POCT) MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 EUROPE POINT OF CARE TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE POINT OF CARE TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE POINT OF CARE TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE POINT OF CARE TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE POINT OF CARE TESTING (POCT) MARKET: SEGMENTATION
FIGURE 10 RISING POPULARITY AMONG PROFESSIONAL ATHLETES IS EXPECTED TO DRIVE THE EUROPE POINT OF CARE TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2021 TO 2029
FIGURE 11 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE POINT OF CARE TESTING (POCT) MARKET IN 2021 & 2029
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE POINT OF CARE TESTING MARKET
FIGURE 13 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, 2021
FIGURE 14 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 15 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, CAGR (2022-2029)
FIGURE 16 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT, LIFELINE CURVE
FIGURE 17 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, 2021
FIGURE 18 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 19 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 20 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 21 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, 2021
FIGURE 22 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, 2022-2029 (USD MILLION)
FIGURE 23 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, CAGR (2022-2029)
FIGURE 24 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY END USER, LIFELINE CURVE
FIGURE 25 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, 2021
FIGURE 26 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, 2022-2029 (USD MILLION)
FIGURE 27 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, CAGR (2022-2029)
FIGURE 28 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY MODE OF TESTING, LIFELINE CURVE
FIGURE 29 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, 2021
FIGURE 30 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 31 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 32 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 EUROPE POINT OF CARE TESTING (POCT) MARKET : SNAPSHOT (2021)
FIGURE 34 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2021)
FIGURE 35 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 36 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 37 EUROPE POINT OF CARE TESTING (POCT) MARKET : BY PRODUCT (2022 & 2029)
FIGURE 38 EUROPE POINT OF CARE (POCT) MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
